Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valérie Le Brun

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
La Revue Du Praticien|April 12, 2003
[The acute swollen red leg]Jean-Marie Bonnetblanc, Valérie Le Brun
Oncology|March 25, 2009
Cardiac toxicity with capecitabine, vinorelbine and trastuzumab therapy: case report and review of fluoropyrimidine-related cardiotoxicityValérie Le Brun-Ly, Jean Martin, Laurence Venat-Bouvet, et al.
Molecular Imaging and Biology|May 25, 2005
In vivo follow-up of rat tumor models with 2-deoxy-2-[F-18]fluoro-D-glucose/dual-head coincidence gamma camera imagingJacques Monteil, Aurélie Dutour, Barbara Akla, et al.
Bulletin Du Cancer|December 18, 2025
[THERANOVA-LIM: Improving access to information on oral treatments for patients and pharmacists]Marion Boucheteil, Sophie Leobon, Kim-Arthur Baffert, et al.
Cardiovascular and Interventional Radiology|May 17, 2018
Pulmonary Thermal Ablation Enables Long Chemotherapy-Free Survival in Metastatic Colorectal Cancer PatientsMariane Fonck, Jean-Thomas Perez, Vittorio Catena, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901Christophe Mariette, Laetitia Dahan, Françoise Mornex, et al.
Annals of Surgery|November 1, 2014
Impact of neoadjuvant chemoradiation on lymph node status in esophageal cancer: post hoc analysis of a randomized controlled trialWilliam B Robb, Laetitia Dahan, Françoise Mornex, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patientsThomas Aparicio, Jean-Louis Jouve, Laurent Teillet, et al.
Journal of Translational Medicine|January 22, 2016
Chemotherapy outcome predictive effectiveness by the Oncogramme: pilot trial on stage-IV colorectal cancerChristophe Bounaix Morand du Puch, Michelle Nouaille, Stéphanie Giraud, et al.
The Lancet. Oncology|April 26, 2025
TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trialAziz Zaanan, Olivier Bouché, Christelle de la Fouchardière, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
La Revue Du Praticien|April 12, 2003
[The acute swollen red leg]Jean-Marie Bonnetblanc, Valérie Le Brun
Oncology|March 25, 2009
Cardiac toxicity with capecitabine, vinorelbine and trastuzumab therapy: case report and review of fluoropyrimidine-related cardiotoxicityValérie Le Brun-Ly, Jean Martin, Laurence Venat-Bouvet, et al.
Molecular Imaging and Biology|May 25, 2005
In vivo follow-up of rat tumor models with 2-deoxy-2-[F-18]fluoro-D-glucose/dual-head coincidence gamma camera imagingJacques Monteil, Aurélie Dutour, Barbara Akla, et al.
Bulletin Du Cancer|December 18, 2025
[THERANOVA-LIM: Improving access to information on oral treatments for patients and pharmacists]Marion Boucheteil, Sophie Leobon, Kim-Arthur Baffert, et al.
Cardiovascular and Interventional Radiology|May 17, 2018
Pulmonary Thermal Ablation Enables Long Chemotherapy-Free Survival in Metastatic Colorectal Cancer PatientsMariane Fonck, Jean-Thomas Perez, Vittorio Catena, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901Christophe Mariette, Laetitia Dahan, Françoise Mornex, et al.
Annals of Surgery|November 1, 2014
Impact of neoadjuvant chemoradiation on lymph node status in esophageal cancer: post hoc analysis of a randomized controlled trialWilliam B Robb, Laetitia Dahan, Françoise Mornex, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patientsThomas Aparicio, Jean-Louis Jouve, Laurent Teillet, et al.
Journal of Translational Medicine|January 22, 2016
Chemotherapy outcome predictive effectiveness by the Oncogramme: pilot trial on stage-IV colorectal cancerChristophe Bounaix Morand du Puch, Michelle Nouaille, Stéphanie Giraud, et al.
The Lancet. Oncology|April 26, 2025
TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trialAziz Zaanan, Olivier Bouché, Christelle de la Fouchardière, et al.
Pageof 2